Pharmaceutical

Orionis and Genentech link on oncology small-molecule glue medicines

Orionis Biosciences has announced a multi-year partnership with Roche’s Genentech for small-molecule monovalent glue medicine.

May 22, 2025 - 06:00
Orionis and Genentech link on oncology small-molecule glue medicines
Orionis Biosciences has announced a multi-year partnership with Roche’s Genentech for small-molecule monovalent glue medicine.
Read the original article

Tags:

Previous Article

Overcoming cold-chain logistical challenges when delivering life-saving MS thera...

Next Article

Moderna shares down after pulling Covid-flu combo vaccine application

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: In response to criticism, FDA publishes new database of wayward clinical trial sponsors

STAT+: In response to criticism, FDA publishes new data...

Dec 15, 2023

Galecto downsizes by 70% following Phase II trial failure

Galecto downsizes by 70% following Phase II trial failure

Sep 27, 2023

Adaptimmune’s Tecelra gains accelerated approval for synovial sarcoma

Adaptimmune’s Tecelra gains accelerated approval for sy...

Aug 3, 2024